Based on our previous observations that 1-O-acetylbritannilactone (R)-4((3aS,4S,7aR)-4-hydroxy-6-methyl-3-methylene-2-oxo-2,3,3a,4,7,7a-hexahydrobenzofuran-5-yl)pentyl acetate (ABL) suppresses prostaglandin E 2 and nitric oxide synthesis in macrophages, the present study was designed to explore the effect of ABL on neointimal hyperplasia after balloon injury and its mechanism of action. In male Sprague-Dawley rats, 26 mg/kg ABL or polyglycol (control) was administered daily from 3 days before injury to 2 weeks after conventional balloon injury. ABL administration led to a significant reduction in neointimal formation (neointima to media ratio, 1.94 Ϯ 0.43 versus 0.84 Ϯ 0.29, P Ͻ 0.01) and proliferative activity of vascular smooth muscle cells after balloon injury in rats. Western blot analysis revealed that this is correlated to the inhibition of nuclear factor (NF)-B activation and to the reduced expression of cyclooxygenase-2. Investigation of potential signaling pathways demonstrated that ABL inhibited NF-B activation via the blockade of the inhibitor of NF-B kinase-␤ activation and the suppression of the degradation of the inhibitors of NF-B-␣. These findings suggest that ABL is a potential inhibitor of neointimal formation because it blocks injury-induced NF-B activation and may have beneficial effects in reducing the risk of restenosis after angioplasty.
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Percutaneous transluminal balloon angioplasty is now widely used in the treatment of obstructed atherosclerotic vessels. However, its overall benefits are limited by the fact that it may induce local arterial restenosis in many patients who are initially treated successfully (Bennett and Schwartz, 1995; Boden et al., 2007) . Although the mechanisms implicated in the process of restenosis have not been completely resolved, accumulating evidence suggests that inflammation plays a key role in neointimal growth after angioplasty (Danenberg et al., 2002; Welt and Rogers, 2002) . The activation of nuclear factor (NF)-B has been found in ballooninjured rat carotid arteries and is involved in the process of neointimal hyperplasia, including growth factor-dependent activation of smooth muscle cell (SMC) proliferation, protease-dependent migration of cells to the wounded area, and cytokine-dependent matrix deposition (Tak and Firestein, 2001; Raines et al., 2004; Raines and Ferri, 2005) . In particular, it has been demonstrated that activation of NF-B is centrally involved in generating the proadhesive phenotype of neointimal smooth muscle cells (Raines et al., 2004; Zeiffer et al., 2004) . Because NF-B is highly activated at sites of inflammation in diverse diseases, it represents a master switch in many inflammatory diseases (Barnes and Karin, 1997; Chen and Shi, 2002) . Thus, interruption of the activation of NF-B by anti-inflammatory drugs and agents could suppress the production of inflammatory mediators and in turn block the initiation and progression of inflammationassociated diseases (Karin, 2005) .
ABL is a new active extract from Inula britannica L., a traditional Chinese medicinal herb (for its structure, see Fig.  1 ). Sesquiterpene lactones from I. britannica have antitumor and immunomodulatory properties and can inhibit the growth of different types of transformed cells (Song et al., 2002; Rafi et al., 2005) . Previous studies showed ABL sup-presses nitric oxide and PGE 2 synthesis in macrophages through the inhibition of inducible nitric-oxide synthase and COX-2 gene expression, indicating modulation of inflammation (Han et al., 2004) . The present study was designed to elucidate the effect of ABL on neointimal hyperplasia in a model of experimental arterial injury.
Materials and Methods

Animals and Pretreatments.
Male Sprague-Dawley rats weighing 290 to 320 g were fed standard laboratory chow and allowed free access to water in an air-conditioned room with a 12-h light/dark cycle. Before the experiment, animals were housed under these conditions for 7 days to allow acclimatization. All animal experiments were approved by the governmental committee for animal research. ABL (99.5% pure), freshly dissolved in 20% polyglycol, was administered orally by gastric gavage from 3 days before balloon injury to 2 weeks after the injury. Six control rats received an equal volume of 20% polyglycol (3 ml/day) in the same manner. Animal body weights were recorded before and at the end of the 2nd week of the experiment.
Balloon Injury Model and after Treatment. Animals were anesthetized with urethane, 600 mg/kg i.p. The thoracic-abdominal artery was de-endothelialized as described previously (Clowes et al., 1983; Capron et al., 1997) . In brief, the catheter was advanced from the left common carotid artery down to the level of the renal arteries three times with a 2F Fogarty catheter (Baxter, McGaw Park, IL) . To attain a constant degree of vessel wall injury for each of the animals, we kept the diameter of the balloon and the resistance during withdrawal constant and the same for each of the animals. All procedures were performed by a single operator.
Morphology Analysis. At 14 days after balloon injury, six crosssections from the middle of each abdominal artery were stained with hematoxylin and eosin. The neointimal and medial areas were calculated using the Image-Pro Plus Analyzer version 5.1 software (Media Cybernetics, Inc., Silver Spring, MD) in a blind manner. For each section, six random, noncontiguous microscopic fields were examined. An algorithm computed the mean thickness (in micrometers) of the intima (I) and media (M) in each field, from which the I/M thickness ratio was derived. To compute the mean thickness values (intima, media, and I/M) of an artery, all measurements performed on the three sections of the artery were averaged. The data are expressed as mean Ϯ S.D.
Measurement of Systemic Inflammation by Serum PGE 2 Enzyme-Linked Immunosorbent Assay. To investigate the effects of ABL on systemic inflammation, serum PGE 2 was measured on day 14 after the balloon injury as one of the systemic inflammation markers. Sham operations, in which the same procedure was conducted except for the inflation of the balloon catheter, were performed in six additional rats at the same time points. Arterial blood was collected into tubes from the arteria cruralis before vessel harvest, and PGE 2 levels were measured in duplicate with a commercial enzyme-linked immunosorbent assay (ELISA) kit purchased from R&D Systems (Minneapolis, MN). The sensitivity of the PGE 2 ELISA was 13.4 pg/ml.
Preparation of Cytosolic and Nuclear Extracts. Harvested abdominal aorta was stripped off the adventitia, immediately suspended in 1 ml of ice-cold hypotonic lysis buffer (10 mM HEPES, pH 7.9, 10 mM KCl, 0.2 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride, and 1 mM dithiothreitol) with protease inhibitor cocktail and homogenized at the highest setting for 1 min in a PRO (PRO Scientific Inc. USA, Shelton, CT) tissue homogenizer. The homogenates were chilled on ice for 15 min and then vigorously shaken for 15 min in the presence of 0.6% Nonidet P-40. The nuclear fraction was precipitated by centrifugation at 8000g for 5 min. The supernatants containing the cytosolic proteins were collected. Nuclear protein was extracted by slow addition of 500 l of high-salt buffer with continuous mixing, and the tube was rocked for 30 min at 4°C. The highsalt buffer consisted of 20 mM HEPES, pH 7.9, 400 mM KCl, 0.2 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, and 1 mM dithiothreitol with protease inhibitor cocktail. The nuclear extract was incubated with continuous shaking at 4°C for 30 min and then centrifuged for 15 min at 13,000g. The supernatants were collected. The protein concentrations of the cytosolic and nuclear extracts were determined using a Quick Start Protein Assay kit (Bio-Rad, Hercules, CA), and then they were aliquoted and stored at Ϫ70°C.
Western Blot Analysis. The cytosolic and nuclear proteins (40 g of protein) were electrophoresed on SDS-polyacrylamide gel and were then transferred onto polyvinylidene difluoride membranes and blotted with specific antibodies against NF-B p65, IB-␣, glyceraldehyde-3-phosphate dehydrogenase (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), IKK-␣, IKK-␤, phospho-IB-␣, and phospho-IKK-␣/␤ (Cell Signaling Technology Inc., Beverly, MA). All bands were quantified by a Bio 1D gel analysis system (Vilber Lourmat, Marne-la-Vallée, France). The molecules in the bands of interest were normalized against glyceraldehyde-3-phosphate dehydrogenase bands and presented as relative density ratios. Electrophoretic Mobility Shift Assay for NF-B. NF-B activation was analyzed by electrophoretic mobility shift assay (EMSA) as described previously (Han et al., 2004) . In brief, nuclear extract (5-10 g) was incubated for 10 min at room temperature with [␥- 32 P]-labeled NF-B probe. The specificity of binding was examined by competition with 100-fold unlabeled double-stranded oligonucleotide. Then, DNA-protein complexes were separated from the unbound DNA probe in native 5% nondenaturing polyacrylamide gels and visualized by autoradiography.
Determination of Proliferative Activity. To determine whether suppressed inflammation is accompanied by the reduced proliferative activity of SMCs, we performed immunohistochemical staining against proliferating cell nuclear antigen (PCNA; Santa Cruz Biotechnology, Inc.), and the percentages of PCNA-positive cells versus total nucleated cells were quantified in three different sectors per tissue section (n ϭ 6 in each group).
Statistics. All of the experiments were repeated at least three times with a similar pattern of results. Data are expressed as the mean Ϯ S.D., and the ABL treatment effects were analyzed by Student's t test using SPSS 11.0 software (SPSS Inc., Chicago, IL). A value of P Ͻ 0.05 was considered to be statistically significant.
Results
Body Weight and Plasma Level of ABL. The mean body weight was not affected by treatment with ABL at 14 days after balloon injury (control group, 305 Ϯ 13 g; ABL-treated group, 298 Ϯ 7 g). The maximum plasma concentration of ABL was reached within 1 to 2 h of drug administration, which was 0.17 Ϯ 0.03 mg/ml (n ϭ 6).
ABL Inhibits Neointimal Hyperplasia. At 14 days after balloon injury, the control animals showed abundant neointimal hyperplasia (Fig. 2C) . The ABL-treated animals showed significant suppression of neointimal hyperplasia and reduction of the I/M ratio (control versus ABL, 1.94 Ϯ (Fig. 2, A and B) .
ABL Inhibits the Production of PGE 2 by Suppressing Injury-Induced COX-2 Expression. To test whether the inhibiting neointimal hyperplasia effect of ABL is related to its anti-inflammatory properties, the effects of ABL on COX-2 gene expression and the production of PGE 2 were examined. Western blot analysis showed that rat arteries uninjured by the balloons produced modest signals, indicating that sham operations might stimulate COX-2 expression to some extent. Balloon injury resulted in high levels of COX-2 expression on day 14 in the control group. In ABLtreated rats, the expression of COX-2 induced by balloon injury was significantly reduced. Densitometric analysis showed that ABL reduced the COX-2 band intensity by 65.7 Ϯ 7.9% (Fig. 3A) . However, COX-2 was not modified directly by ABL (data not shown). Moreover, balloon injury resulted in a clear increase in the serum PGE 2 level, which was reduced by 63.7 Ϯ 9.4% on day 14 after balloon injury in ABL-treated rats (control versus ABL, 2600 Ϯ 195 versus 945 Ϯ 136 pg/ml, n ϭ 6; ‫,ء‬ P Ͻ 0.01) (Fig. 3B ). In addition, we observed a positive correlation between the serum PGE 2 level and COX-2 expression 14 days after the injury (Pearson correlation coefficient, 0.947; n ϭ 12; P Ͻ 0.001, two-tailed) (Fig. 3C) .
ABL Suppresses NF-B Activation by Inhibiting IB-␣ Phosphorylation and Nuclear Translocation of P65. We found that the injury-induced expression of p65 started to increase at day 1 after balloon injury and reached Fig. 2 . Neointimal hyperplasia 14 days after balloon injury. Representative sections of a hematoxylin and eosin-stained arterial section from the control (A and C) and from the ABL-treated (B and D) rats. ABL treatment significantly reduced neointimal hyperplasia. Magnification, ϫ400. E, morphometric data. ‫,ء‬ P Ͻ 0.01 versus injured group. n ϭ 6 in each group. Fig. 3 . ABL inhibited PGE 2 production and COX-2 expression induced 14 days after balloon injury. A striking reduction in the expression of COX-2 was observed in the balloon-injured arteries of ABL-treated rats compared with the controls. At the bottom, the bar graph shows a densitometric analysis of Western blot data (A). Serum PGE 2 levels were determined by ELISA. Control balloon injury increased the serum PGE 2 to a higher level than in uninjured rats, and the level was significantly reduced by ABL treatment (B). ‫,ء‬ P Ͻ 0.01 versus injured group. n ϭ 6 in each group. Moreover, a strong positive correlation was found between the serum PGE 2 level and COX-2 expression on day 14 (B) (n ϭ 12, Pearson correlation coefficient ϭ 0. 947, P Ͻ 0.001). Data shown were obtained as described in Figs. 2E and 4C . These results demonstrated that ABL treatment inhibits NF-B-DNA binding activity, which is associated with neointimal formation (n ϭ 12, Pearson correlation coefficient ϭ 0. 940, P Ͻ 0.001). E, ABL inhibited the nuclear translocation of p65. Western blot analysis showed ABL suppressed the translocation of p65 into the nucleus at 14 days after balloon injury. F, ABL suppressed IB-␣ degradation and phospho-IB-␣ on day 14. At the bottom, densitometry analyses of Western blot are provided as the mean Ϯ S.D. of three separate experiments. ‫,ء‬ P Ͻ 0.01 versus injured group. n ϭ 6 in each group.
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at ASPET Journals on October 15, 2017 jpet.aspetjournals.org the peak level at day 14 (Fig. 4A) . To explore the effect of ABL on p65 expression, Western blot was performed on arterial samples at 14 days after balloon injury. At this time point, the p65 expression was reduced by 42.9 Ϯ 5.7% in the ABLtreated group compared with the injured group (Fig. 4B) .
To investigate whether NF-B is a significant target for the anti-inflammatory action of ABL in balloon injured animals, we examined the effect of ABL on NF-B activation by performing an EMSA. The results, presented in Fig. 4C , showed a low level of NF-B-DNA binding activity was detected in nuclear protein extracts from arteries of control rats. Conversely, a strong NF-B p65-specific gel-retarded band was detected in samples derived from balloon-injured animals (Fig. 4C, lane 3) . The binding of NF-B p65 is DNA-specific because the band disappeared in the presence of an excess of unlabeled NF-B oligonucleotides (Fig. 4C, lane 5 ). In contrast, faint gel-retarded bands were found in samples from ABL-treated animals (Fig. 4C, lane 4) . Furthermore, we also performed a Pearson correlation analysis to determine whether ABL-induced suppression of neointimal hyperplasia resulted from the reduced NF-B activity. Our analysis (shown in Fig. 4D ) indicated a positive correlation between the DNA-binding activity of NF-B and the I/M ratio 14 days after balloon injury (Pearson correlation coefficient, 0.940; n ϭ 12; P Ͻ 0.001, two-tailed).
Nuclear translocation of the Rel family protein p65, as a marker for NF-B activation, was also determined. As shown in Fig. 4E , balloon injury stimulated the translocation of p65 into the nucleus. However, ABL treatment suppressed the translocation of the cytosolic p65 subunit to the nucleus in the injured arteries of ABL-treated rats on day 14. The effect of ABL on the degradation of IB-␣ was also examined. At this time point, balloon injury resulted in a significant increase in IB-␣ degradation, whereas this effect was significantly blocked by ABL treatment. Meanwhile, the level of phosphorylated IB-␣ was reduced to 15.0 Ϯ 3.6% in comparison with the injured group (Fig. 4F) .
ABL Inhibits the Expression and Phosphorylation of IKK-␤.
To elucidate the molecular mechanisms of the ABLlimited neointimal hyperplasia, further experiments were conducted to explore the pathway by which ABL diminishes the inflammatory response induced by the balloon injury. Phosphorylation of IKKs is a critical step and a point of convergence in the NF-B activation pathways (Karin, 1999; Karin and Ben-Neriah, 2000) . ABL completely blocked the expression of IKK-␤ triggered by balloon injury on day 14 but did not affect that of IKK-␣. Then, we examined the effects of ABL on IKK phosphorylation. Likewise, the phosphorylation of IKK-␤ was dramatically attenuated by ABL. Interestingly, the phosphorylation level of IKK-␣ was unaltered (Fig. 5) . Thus, it was speculated that ABL inhibited IB-␣ phosphorylation by specifically suppressing that of IKK-␤.
Effect of ABL on the Proliferative Activity of SMCs. Suppressed inflammation was accompanied by a reduction in the proliferative activity of SMCs. We stained sections for PCNA expression in representative fields from each artery and determined the percentage of PCNA-positive nuclei in the neointima. The number of PCNA-positive cells in the neointimal and medial layers of the arteries remarkably decreased in ABL-treated rats 14 days after injury, compared with the control animals (Fig. 6, C and D) . At day 14, the PCNA-positive percentage in controls was 36.4 Ϯ 9.8%, whereas in the ABL-treated group, it was 14.9 Ϯ 4.2% (P Ͻ 0.01).
Discussion
The activation of the inflammatory response to vessel injury has been shown in numerous studies to play a predominant role in the development of postangioplasty restenosis (Bu et al., 2005; Chandrasekar et al., 2006) . Vessel injury is associated with the induced expression of the proinflammatory genes, including vascular cell adhesion molecules, cytokines, growth factors, and proinflammatory enzymes, which are the mechanisms leading to SMC proliferation, vessel wall remodeling, foam cell accumulation, and neointimal hyperplasia.
ABL is a natural substance, extracted from the traditional Chinese medicinal herb I. britannica L. In vitro studies have suggested that the anti-inflammatory effect of ABL involves blocking the binding of NF-B to the promoter in the target genes and inhibiting the expression of the proinflammatory genes by suppressing lipopolysaccharide-induced IB degradation in macrophages (Han et al., 2004) . In the present investigation, the effects of ABL on NF-B activation, an important mediator of inflammation, cell proliferation, and restenosis, were studied. Our results indicate that administration of ABL in vivo leads to a significant reduction in neointimal thickness by Ϸ56.7% (Fig. 2) 2 weeks after angio- plasty. The study demonstrates that ABL is a potent inhibitor of NF-B activation by specifically suppressing the phosphorylation of IKK-␤ with consequent inhibition of NF-B translocation and of IB degradation. Furthermore, we observed a positive correlation between NF-B activation and the degree of neointimal hyperplasia.
NF-B is a crucial transcription factor driving the inflammatory response (Tak and Firestein, 2001; Chen and Shi, 2002; Raines et al., 2004) . NF-B dimers are sequestered in the cytoplasm in an inactive form associated with regulatory proteins called IB. Inflammatory stimuli such as lipopolysaccharide, interleukin-1, and tumor necrosis factor-␣ cause phosphorylation of IB-␣ and its subsequent degradation, allowing translocation of NF-B to the nucleus, where it binds to the promoters of NF-B regulatory genes and initiates transcription of the proinflammatory gene Scherer et al., 1995; Ghosh et al., 1998; Huxford et al., 1998; Hoffmann et al., 2002) . The evidence that inflammation mediated by NF-B is involved in postangioplasty lumen narrowing suggests that NF-B plays a causative role in the development of restenosis (Bu et al., 2005; Chandrasekar et al., 2006) . The fact that NF-B/IB-␣ complexes shuttle constitutively between the cytoplasm and the nucleus provides us with a new idea that the regulation of this important signaling pathway is a prospective clue to preventing a potential inflammatory response (Birbach et al., 2002; Kitamoto et al., 2003; Tsatsanis et al., 2006) . Thus, the suppression of NF-B-dependent inflammatory gene expression may be an extremely effective therapeutic strategy for preventing inflammatory processes and neointimal growth (Kitamoto et al., 2003) .
It has been reported that the use of antisense oligonucleotides to the p65 subunit of NF-B could reduce neointimal formation by inhibition of SMC proliferation and adherence (Autieri et al., 1995) . Moreover, studies using gene delivery to overexpress IB-␣ have been shown to be effective in suppressing neointimal formation in a rabbit restenosis model (Breuss et al., 2002) . These studies, together with the present results, point toward NF-B as an attractive therapeutic target for intimal thickening. Supporting the role of the inhibitory effect of ABL on inflammation as a causal mechanism was the suppression of IB-␣ phosphorylation and the activation of NF-B. These were confirmed by EMSA and Western blot. ABL treatment reduced NF-B-DNA binding activity by 43.4 Ϯ 7.9% (Fig. 4C ) and the IB-␣ phosphorylation by 85.1 Ϯ 3.6% (Fig. 4F) . To elucidate the molecular mechanisms leading to the inhibition of NF-B activation by ABL, we explored the local expression of IKK in injured arteries. The IKK complex is the point of convergence in the cascade of NF-B activation. Given the potent IKK activity in intima and the role for IKK␤-mediated NF-B signaling in inflammation, we further provide experimental evidence that ABL specifically inhibits phosphorylation of IKK-␤ triggered by balloon injury (Fig. 5) . These findings are consistent with previous data from the literature indicating that IKK-␤ represents a key target of various NF-B inhibitors, including manumycin A and peroxynitrite (Levrand et al., 2005; Bernier et al., 2006) . Although ABL blocked IKK-␤ phosphorylation, it did not affect IKK-␣ phosphorylation. This indicates that there may be a unique mechanism by which ABL specifically inhibits phosphorylation of IKK-␤, which requires further investigation to acquire more evidence. Taken together, these results indicate that the effect of ABL may be dependent on the phosphorylation of IKK-␤.
In the present study, we measured the serum PGE 2 level, which is tightly coupled with the COX-2 protein expression that increased after balloon injury in vivo. It has been reported that prostaglandins might influence the development of restenosis and intimal hyperplasia (Connolly et al., 2002) . PGE 2 enhanced platelet aggregation, chemotaxis of leukocytes, vascular permeability, and vascular cell adhesion molecule expression, thus resulting in serious damage in the arterial walls (Roviezzo et al., 2005; Chen et al., 2006; Kamachi et al., 2007) . Therefore, we believe that not only local inflammations but also systemic inflammations, as measured by serum PGE 2 , play an important part in the development of neointimal hyperplasia. Such findings are supported by other studies, which showed that nonspecific systemic inflammation can aggravate neointimal hyperplasia after balloon injury in the rat (Park et al., 2004) . This interpretation is consistent with the positive correlation between the reduced blood serum PGE 2 level and the downregulated expression of COX-2 protein (Fig. 3C) . In this study, we found that ABL suppressed the local expression of COX-2 significantly, which not only affects PGE 2 biosynthesis but also reduces the vascular inflammatory response. We assume in our studies that the reduced level of PGE 2 might be responsible for the decreased risk of restenosis. However, we observed that ABL did not have a significant modification on COX-2. Thus, the decrease in PGE 2 level by ABL resulted from inhibition of COX-2 expression. It is possible to hypothesize that circulating PGE 2 synthesis may be induced from sources other than the injured arteries, and inhibition of NF-B activation by ABL may cause a decreased expression of other molecules, which is the downstream of NF-B and related to the COX-2 gene expression.
It is well established that SMCs are the major cellular component of neointimal lesions, and proliferation of SMCs plays an important role in the pathogenesis of restenosis. PCNA is synthesized in early G 1 and S phases of the cell cycle and thus can be used as a marker for cell proliferation. For this, we examined the effects of ABL treatment on SMC proliferation after balloon injury on day 14. The results showed that ABL diminished the number of PCNA-positive cells in the neointima (Fig. 6 ). These findings suggest that ABL may suppress inflammatory neointimal hyperplasia after balloon injury not only by anti-inflammation but also by inhibition of SMC proliferation. The inhibition of proliferation may also contribute to the reduced levels of inflammatory proteins and transcription factors found in lesions of ABL-treated rats. All of these effects of ABL may be beneficial in the prevention of neointimal hyperplasia.
In conclusion, this is the first study to demonstrate that ABL inhibits neointimal hyperplasia after angioplasty. The inhibition is associated with the modulation of vascular inflammation and inhibition of SMC proliferation via attenuation of IKK-NF-B signaling. Besides providing novel insights into the protective action of ABL in the vascular injury response, these results offer a potential therapeutic strategy of ABL in the prevention and treatment of cardiovascular inflammatory diseases and restenosis after angioplasty.
